The Dynamics of Glutathione Species and Ophthalmate Concentrations in Plasma from the VX2 Rabbit Model of Secondary Liver Tumors by Abbas, R. et al.
Hindawi Publishing Corporation
HPB Surgery
Volume 2011, Article ID 709052, 8 pages
doi:10.1155/2011/709052
Research Article
The Dynamics of Glutathione Speciesand Ophthalmate
Concentrations in Plasma from the VX2 Rabbit Model of
SecondaryLiverTumors
R.Abbas,1 R. S. Kombu,2 R.A.Ibarra,1,2 K. K. Goyal,1 H.Brunengraber,1,2
andJ. R. Sanabria1,2
1Division of Transplant and Hepatobiliary Surgery, Department of Surgery, Case Western Reserve University School of Medicine and
University Hospitals, Case Medical Center, 11100 Euclid Avenue, Lakeside 7510, PS 5047, Cleveland, OH 44106, USA
2Department of Nutrition, Case Western Reserve University School of Medicine and University Hospitals, Case Medical Center,
11100 Euclid Avenue, Lakeside 7510, PS 5047, Cleveland, OH 44106, USA
Correspondence should be addressed to J. R. Sanabria, juan.sanabria@uhhospitals.org
Received 26 June 2010; Accepted 11 January 2011
Academic Editor: Christos G. Dervenis
Copyright © 2011 R. Abbas et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Purpose. Available tumor markers have low sensitivity/speciﬁcity for the diagnosis of liver tumors. The present study was designed
to evaluate the oxidoreductive status of the liver as surrogates of tumor subsistence and growth. Methods. Glutathione species
(GSH:GSSG), ophthalmate (OA) concentrations, and their turnover were measured in plasma of rabbits (n = 6) in their healthy
state and in the state of tumor growth after implantation of the VX2 carcinoma in their liver. Tumors were allowed to grow for a
periodof14dayswhenrabbitsweresacriﬁced.Liverswereremovedandcysteineconcentrationwasmeasuredinlivertissue.Results.
Tumor growth was found in 100% of the rabbits. Concentration and labeling of GSH/GSSG were similar in experimental animals
before and after tumor implantation and to sham animals. In contrast, OA concentration increased signiﬁcantly in experimental
animals after tumor implantation when compared to same animals prior to tumor implantation and to sham animals (P<. 05).
The concentration of cysteine, a precursor of GSH, was found to be signiﬁcantly lower in the liver tissue adjacent to the tumor
(P<. 05). Conclusion. Disturbances in the oxidoreductive state of livers appear to be a surrogate of early tumor growth.
1.Introduction
Livertumorsare thethird mostcommonmalignancies ofthe
gastrointestinal tract worldwide [1]. In the Western World,
secondary liver tumors are more frequent than primary
ones, even though the incidence of hepatocellular carcinoma
(HCC) has been increasing over the last 20 years, especially
in males [2]. Nearly 80% of liver tumors are diagnosed
in advanced stages precluding curative therapies [3], and
tumor markers for the early detection of liver growth
lack high levels of sensitivity and speciﬁcity. Currently, α-
fetoprotein (AFP) and carbohydrate antigen 19.9 (CA19.9)
are the most frequently used serum markers to detect hep-
atocellular carcinoma and cholangiocarcinoma, respectively
[4–9]. Carcinoembryonic antigen (CEA) is frequently used
for detection and followup of colorectal liver metastases
[10]; however it may be increased in many other medical
conditions. The ideal biomarker for early detection of liver
cancer would be speciﬁc for the malignant condition and
sensitive enough to detect the neoplasm at an early stage,
when treatment is still possible [11]. Serum metabolites
related to oxidative stress are thought to be a potential
biomarker for the early detection of cancer [12, 13].
Patients with advanced malignancy are typically in a
catabolic state. Tumor necrosis factor-α(TNF-α) and other
cytokines have been implicated in promoting a low-energy
intake with increased energy expenditure and negative
energy balance, likely due to tumor growth [12]. Mantovani
et al. found a signiﬁcant elevation in TNF and IL-6 along
with a reduced activity of the enzyme glutathione peroxidase
in patients with advanced stages of various cancers (stage III
or IV) [13]. Glutathione peroxidase is considered a surrogate2 HPB Surgery
marker for body oxidative stress and its reduction may
be due to a reduction of its substrate availability, reduced
glutathione [12, 13]. In addition, reduced glutathione con-
centrations in plasma were signiﬁcantly lower in patients
with advanced cancer from diﬀerent organs including renal,
breast, lung, and colon cancers [14–16]. The glutathione
(GSH:GSSG) redox couple is one of the main cellular
defenses against oxidative stress [14–17]. Failure of the
glutathione redox buﬀer system may result in mitochondrial
failure and cell apoptosis. Ophthalmate (OA) is an analogue
of glutathione in which the cysteine moiety is replaced by
L-2-aminobutyrate, a catabolite of threonine. OA synthesis
occurs when same enzymes that catalyze the assembling of
glutathione ﬁnd cysteine availability low [17]. It was recently
reported that the concentration of ophthalmate in rat liver
and plasma increases when oxidative stress is induced by
acetaminophen [17]. The liver has the highest concentration
of reduced glutathione in the body, but the liver ophthalmate
pool is very small (1% of the size of GSH:GSSG) since it is
actively transported out of the cell [17]. We hypothesized
that early stages of liver tumor growth may enhance cell
oxidative stress with alterations of the redox state of the
glutathione system, promoting an increase in ophthalmate
concentration.
Our laboratory developed a technique of stable iso-
topomer analyses for the measurement of the GSH/GSSG/
OA redox system by the labeling of glutathione species and
OA from a deuterated water (2H2O) load [18]. In addition,
the VX2 rabbit model is a reliable model of secondary
liver tumors. First developed by Shope and Hurst in 1933
[19], the VX2 carcinoma is an anaplastic squamous cell
carcinoma derived from a virus-induced papilloma. It has
been extensively used to induce the growth of secondary
liver tumors [20–24]. Thus, to test our hypothesis we made
use of both the VX2 model and of new mass spectrometric
techniques to measure the concentration and labeling of
the GSH/GSSG/OA redox system from deuterium-enriched
body water [18].
2.MaterialsandMethods
2.1. VX2 Cell Line. The VX2 cell line was obtained from
Dr. A. Exner Laboratory (Case Western Reserve University
School of Medicine, Cleveland, OH). Tumor donor rabbit
(F1; n = 1) was developed by intramuscular injection of
the VX2 cell line in the thigh muscle (Vastus lateralis) of a
New Zealand white male rabbit as previously described in
[25]. After four weeks, the tumor was harvested and minced
into tissue cubes of 1.0mm3 and saved at −70◦Ci nF B S
with 10% DMSO until implantation. On the day of tumor
implantation, grafts were thawed and washed three times
in Hanks’ Buﬀered Salt Solution (HBSS). General chemicals
and reagents were obtained from Sigma-Aldrich (St Louis,
MO). Deuterated water (2H2O at 99.9%, glass distilled) was
procuredfromIsotec(Miamisburg,OH).Fetalbovineserum
was obtained from Cambrex (East Rutherford, NJ).
2.2. Animal Model. Adult New Zealand white male rabbits
(n = 8;Covance,Princeton,NJ)weighing2,500–3,000gwere
placed in quarantine for 15 days prior to any experiment and
kept under standard conditions of day cycle, temperature,
and humidity with food (Rabbit chow, NJ) and water
ad libitum. Studies on the animals were approved by the
Institutional Animal Care and Use Committee (IACUC) at
Case Western Reserve University and carried out according
to its guidelines.
A l ls u r g i c a lp r o c e d u r e sw e r ep e r f o r m e du n d e rs t e r i l e
conditions and under the inﬂuence of intramuscular anes-
thesia with Xylazine (5mg/kg), Ketamine (50mg/kg), and
Acetylpromazine (10mg/kg). Depth of anesthesia was mon-
itored by recording heart rate, respiratory rate, eye reﬂex,
and response to stimulus. Surgical site was shaved and
swabbed with Providian-iodine solution (Betadine, MI) and
Marcaine 0.25% without epinephrine was administered sub-
cutaneouslyforlocalanesthesia.Tumorrecipientrabbits(F2;
Experimental Group, n = 6) underwent median laparotomy
with implantation of VX2 tumors at two separate liver sites
(right medial and right posterior lobes) through a 2mm
incision in the liver capsule and each site was closed and
labeled with a 6:0 Prolene suture (Ethicon, NJ). All animals
received equal tumor load. Other rabbits underwent similar
operative procedures with the implantation of Gelfoam
(Ethicon, NJ) as grafts. They served as a control group (F2;
Sham group, n = 2) (Figure 1).
Rabbits were given buprenorphine (0.3mg/mL at a dose
of 0.1mg/kg) (Sigma, MO) administered subcutaneously
twice daily for two days following any procedure. Peni-
cillin (300,000units/mL at a dose of 50,000units/kg) and
gentamicin (40mg/mL at a dose of 3mg/kg) were injected
subcutaneously (SC) prior to the procedure and once daily
for the two postoperative days. 20mL of normal saline (0.9%
NS) was given SC after the procedure for insensible water
losses. All animals were monitored three times a day for 72
hours and then twice a day until animals were sacriﬁced. No
animals had any sign of infection or sickness.
2.3. Tumor Growth Assessment. Animals, two weeks after
tumor implantation, underwent surgicalremovalof the liver.
Biopsies of liver tissue adjacent to the tumor and from
healthytissuefromthelobewithouttumorwereimmediately
frozen on liquid nitrogen, labeled and stored at −80◦Cf o r
further analysis and the rest was perfused-ﬁxed with 10%
formaldehyde and 90% PBS at room temperature. Slides of
liver tissue from normal and tumor growth were paraﬃn
embedded and submitted for standard Hematoxylin and
Eosin (H & E) staining. Blinded slides were assessed by two
authors for evidence of tumor development. Tumors size
and tumor volume were calculated from digital records. The
largest tumor diameter and its calculated area were saved
from each tumor using Digi3 Digital Binocular Microscope
with DigiPro3.0 software (LaboMed, CA).
2.4. Labeling of Total Body Water and Blood Samples. F2
rabbits were injected intraperitoneally with saline made up
in deuterated water 14 days prior and 10 days after the tumor
implantationsurgery.Thevolumeofinjectionwascalculated
to achieve a 5% 2H-enrichment in body water, assuming
that total body water accounts for 2/3 of body weight. SinceHPB Surgery 3
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Figure 1: Experimental design using the VX2 rabbit model of secondary liver tumors. The VX2 cell line was implanted in the muscle of F1
rabbits 4 weeks prior to tumor procurement. The experimental group was formed by rabbits where 1mm3 tumor grafts were implanted in
their liver. The Sham group consisted of rabbits that underwent similar operation, but 1mm3 pieces of gelfoam were implanted in their liver.
Enrichment of body water was achieved at 5% of total body water, and blood samples were taking at days −13, −12, and −11 prior to tumor
implantation and at days +11, +12, and +13 after tumor implantation.
the oxidation of foodstuﬀs and endogenous substrates yields
unlabeled water, the rabbits were given 5% 2H-enriched
drinking waterfor72hours.Blooddraws(1.5ml)weretaken
for3consecutivedaysfromthemarginalearveinatdays−13,
−12, and −11 from tumor implantation (day 0) and at days
+11, +12, and +13 after tumor implantation. The amount of
bloodandthenumberofdrawswereregulatedbytheAnimal
Committee at Case. All F2 animals were sacriﬁced after liver
removal on day +14. Plasma was isolated after centrifugation
at3,000rpmat4◦Cfor10min.Topreventitsoxidation,GSH
was immediately converted to a stable thioether by treating
100μl of plasma with 100μlo f5 0m Mi o d o a c e t a t ei n1 0m M
ammonium bicarbonate, pH 10, adjusted with concentrated
ammonia [18]. Aliquots were saved on liquid nitrogen and
stored at −70◦C for LC-MS/MS processing.
2.5. Mass Spectrometry Analysis. Glutathione species and
ophthalmate concentrations and labeling were measured in
plasma samples with mass spectrometry methods. Liquid
chromatography-mass spectrometry (LC-MS/MS) process-
ing details are described elsewhere [18]. Homo-glutathione
was obtained from Chem-Impex International Inc. (Wood
Dale, IL) and Ophthalmate from Bachem (Torrance, CA).
Acetonitrile and DMSO were procured from Fisher Scientiﬁc
(Pittsburgh, PA). In brief, a Hypersil Gold C18 column
(2.1 × 150mm, 5μm particle size; Thermo Electron Corp.)
w a sk e p ta ta m b i e n tt e m p e r a t u r e .M o b i l ep h a s eAw a s
0.15% formic acid in water-acetonitrile (99:1, vol/vol),
and mobile phase B was 0.15% formic acid in water-
acetonitrile (5:95 vol/vol). Using a gradient elution, the
compounds were eluted at a ﬂow rate of 0.2ml/min. The
liquid chromatograph (Agilent 1100; Agilent Technologies
Inc., Palo Alto, CA) was coupled to an API 4000QTrap
mass spectrometer (Applied Biosystems, Foster City, CA)
operated under positive ionization mode. Analyst soft-
ware (version 1.4.1; Applied Biosystems) was used for
data registration. The MRM ion pairs were monitored to
acquired data used to calculate isotopic enrichments from
precursor→product pairs. The ion pairs monitored were
(i) for carboxymethyl-GSH: 366.1→237.2, 367.2→237.1,
and 367.2→238.1, (ii) for cyanomethyl-GSH derived from
GSSR: 347.2→272.1, 348.2→218.1, and 348.2→219.1, (iii)
for carboxymethyl-homo-glutathione: 380.1→233.1, (iv) for
cyanomethyl-homo-glutathione: 361.1→232.1, and (v) for
ophthalmate:290.3 → 161.1,291.3 → 161.1,291.3 → 162.1.
The M3 mol percent enrichment of the GSH derivative is
calculated as M3/(M + M1 + M2 + M3). The [GSH]/[GSSG]
ratio was calculated using the formula (GSH)/(GSSG/2). All
samples were analyzed in triplicates.
Liver tissue was processed and submitted to Gas
Chromatography-Mass Spectrometry (GC-MS) for mea-
surement of cysteine. Powdered frozen tissue (25mg) spiked
with 5nmol of heptadecanoic acid (C17) as internal standard
wasextractedwith2mlofCH3CN/Methanol(1:1precooled
at −12◦C and degassed with N2 ﬂow) using a Polytron
homogenizer. The slurry was centrifuged at 3800rpm for
3 0m i n u t e sa t4 ◦C. The supernatant was collected and dried
with Nitrogen gas ﬂow.
Derivatization was carried out in two steps: 30μlo f
15mg/ml of methoxyamine hydrochloride in dry pyridine
was added to samples and incubated at 30◦Cf o r9 0m i n u t e s .
After this 70μl of N-Methyl-N-trimethylsilyltriﬂuoroacet-
amide with 1% trimethylchlorosilane (MSTFA + 1% TMSC)
was added and the mixture was incubated again at 37◦C4 HPB Surgery
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Figure 2: Macroscopic and microscopic morphology of secondary liver tumors. VX2 tumor cell grafts were implanted in liver from rabbits 14
days prior to tumor removal. All implanted tumor grafts showed macroscopic growth on liver sites. Some growths were observed to have
a ﬂat growth (a) while some others have a nodular growth (b). At histology, most tumors had a pseudocapsule formed by ﬁbrotic tissue
surrounded the tumor ((c) x20). Typical epithelial cells with malignant morphology are seen, however no neoangiogenesis, tumor invasion,
or lymphocyte inﬁltration was seen at this stage of tumor growth ((d) x40). Typical normal liver rabbit tissue is seen in the rest of the organ
((e) x40).
for 40min. Analyses were carried out on an Agilent 5973
mass spectrometer, linked to a model 6890 gas chromato-
graph equipped with an autosampler. A Phenomenex ZB-
5 MSi capillary column was used (30m Length, 0.25mm
ID, 0.25μm ﬁlm thickness). The carrier gas was helium
(1.67psig) and injection was 1μl in splitless mode. The GC
temperature program was: initial temperature 60◦C, hold for
1min, increase by 10◦C/min to 325◦C, and hold 10min. The
injector temperature was set at 250◦C and the transfer line
at 275◦C. EI source and quadrupole temperatures were set
250◦C and 150◦C, respectively. Raw data was deconvoluted
with AMDIS software. Peak identiﬁcation was carried out by
matching retention time and mass spectra similarity against
the Metabolomic Fiehn library (Agilent Technologies Inc,
Santa Clara, CA). For further quantiﬁcation, the data was
exportedtotheSpectConnectserver(MassachusettsInstitute
of Technology, Cambridge, MA). The relative concentration
of cysteine was expressed as its relative area (divided by the
area of the internal standard in the same chromatogram).
2.6. Statistical Analysis. Mean values ± standard deviations
are presented (mean ± SD). Paired Students t-test was used
tocalculatesigniﬁcanceofdiﬀerenceinthemeanvaluesfrom
similar groups before and after tumor implantation (SPSS
16.0, Windows version licensed to Case Western Reserve
University). ANOVA and one-sided independent Students t-
test were used to calculate signiﬁcance of diﬀerence in the
meanvaluesbetweentheexperimentalgroupandthecontrol
group.AP value<. 05wasconsideredstatisticallysigniﬁcant.
3. Results
Tumor growth was found in all six animals (100%) at
the time of sacriﬁce two weeks after tumor implantation
(Figure2).Themeansizeoftumorgrowth(n = 12tumorsin
6animals)was8.4 ±5.96mm(mean ±SDofmax.diameter)
and tumor volume was 241.8 ± 78.6mm3.T u m o rv o l u m e
was similar between lobes and among animals. Rabbits from
the control (sham) group had normal livers with no visible
Gelfoam on second laparotomy. Rabbits showed no sign of
sickness prior to sacriﬁce or metastatic disease at sacriﬁce.
Plasma concentrations of reduced glutathione (GSH) and
oxidized-bound glutathione (GSSR) were not signiﬁcantly
diﬀerent in rabbits from the experimental group before
and after tumor implantation (P>. 05, paired t-test)
(Figure 3). Glutathione plasma concentrations from rabbits
in the experimental group, either before or after tumor
implantation, were similar to the ones in the sham group
(P>. 05, one sided t-test) (Figure 3). Furthermore, the label-
ing of GSH and GSSR in plasma was similar in experimental
rabbits before and after tumor implantation (P>. 05 by
ANOVA and by independent student t-test at 24, 48, and 72
hoursafterdeuteriumenrichment)(Figures4-5).Labelingof
glutathione species in plasma, was also similar in experimen-
tal animals when compared to sham animals (P>. 05).
Ophthalmate plasma concentration before tumor
implantation was similar in rabbits from the experimental
group when compared to the control (sham) group (P>. 05,
one-sided independent t-test) (Figure 6). In contrast, plasma
concentrations of ophthalmate were signiﬁcantly higherHPB Surgery 5
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Figure 3: Glutathione species in plasma from the VX2 rabbit model.
Both the reduced form (GSH) and the oxidized form (GSSG) of
glutathione were measured in plasma from rabbits 2 weeks before
and 2 weeks after tumor implantation. Levels of GSH, GSSG and
GSH/GSSG ratio were similar from the experimental group and the
sham group before and after tumor implantation (P>. 05, paired
t-test and one-sided independent t-test).
in rabbits from the experimental group when compared
to the sham group, after tumor implantation at all time
points (P<. 05, ANOVA and one-sided independent
t-test). Furthermore, plasma concentrations of ophthalmate
were signiﬁcantly higher in rabbits from the experimental
group in the state of tumor growth when compared to
concentrations at their healthy state (P<. 05, paired t-test).
The plasma concentration of ophthalmate was similar in
the control group before sham surgery when compared
to the levels from the same group after sham surgery
(P>. 05, paired t-test). Plasma labeling of ophthalmate
in experimental animals in their status of health was
comparable to the labeling in their status of tumor growth
and to sham animals (P>. 05, by ANOVA and independent
student t-test at 24, 48, and 72 hours after deuterium
enrichment) (Figure 7). The relative concentration of
cysteine, an amino acid precursor of GSH, was found to
be signiﬁcantly lower in liver tissue adjacent to the tumor
when compared to liver tissue from the lobe not containing
tumor (P<. 05 paired t-test, Figure 8). Liver tissue
relative concentrations of cysteine were similar between the
experimental group (both liver adjacent to the tumor and
liver away from tumor) when compared to the sham group
(P>. 05, independent t-test).
4. Discussion
We hypothesized that animals undergoing early tumor
growth may be subject to an increase oxidative stress with
disturbance of their GSH/GSSG redox buﬀer system, and
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Figure 4: Labeling of reduced glutathione (GSH) in plasma from the
VX2 rabbit model. The turnover of reduced glutathione (GSH) was
measured in plasma from rabbits 2 weeks before and 2 weeks after
tumor implantation. GSH was found to be similar in rabbits from
the experimental group before and after tumor implantation and
to sham animals (P>. 05, paired t-test and one-sided independent
t-test).
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Figure 5: Labeling of oxidized-bound glutathione (GSSG) in plasma
from the VX2 rabbit model. The turnover of oxidized-bound
glutathione (GSSG) was measured in plasma from rabbits 2 weeks
before and 2 weeks after tumor implantation. GSSR was found to
be similar in rabbits from the experimental group before and after
tumorimplantationandtoshamanimals(P>. 05,pairedt-testand
one-sided independent t-test).
a parallel increase in the production of ophthalmate. The
present studies showed that both the concentrations as well
as the labeling of glutathione species were similar in the
state of health compared to the state of early tumor growth
in the VX2 rabbit model. In contrast, the concentration of
OA increased signiﬁcantly from animals in the state of early
tumor growth when compared to their healthy state and6 HPB Surgery
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Figure 6: Ophthalmate (OA) concentration in plasma from the
VX2 rabbit model. The concentration of OA was measured in
plasma from rabbits 2 weeks before tumor implantation and 2
weeks after tumor implantation. Levels of OA were similar in
rabbits from the experimental group before tumor implantation
when compared to the control (sham) group (P>. 05, one-sided
independent t-test). In contrast, levels of OA were signiﬁcantly
higher in the experimental group when compared to the sham
group after tumor implantation (P<. 01, one-sided independent
t-test). Furthermore, levels of OA were signiﬁcantly higher in the
experimental group in the state of tumor growth when compared
to the state of health (P<. 01, paired t-test).
to sham animals. The small size of the ophthalmate pool
makesOAapotentialsensitiveindexofoxidativestresslinked
to variations in the rate of GSH synthesis and of cysteine
availability [17]. The turnover of the glutathione species
pool in the liver occurs rapidly, 2-3% per minute in the
basal rate, even though its large size. While the plasma pool
of GSH:GSSG is very small, its turnover is similar to that
of the liver. Thus, the turnover of plasma GSH:GSSG is a
proxy of the turnover of the liver GSH:GSSG [18]. In this
animal model, a secondary liver tumor grew for two weeks
compared to a control (sham) group. The concentrations of
plasma GSH and GSSG as well as the [GSH]/[GSSG] ratio
and their plasma labeling were similar in this model of early
tumor growth compared to controls. Using the turnover of
glutathione species in plasma as a proxy of the liver [18], the
previous ﬁnding may suggest the strength of the glutathione
redox buﬀer system in the nonaﬀected liver lobe in the
early stage of tumor growth. Intracellular GSH oxidation in
further developed to advanced and undiﬀerentiated tumors
is associated with an increase in glutathione peroxidase
activity with further increase in its oxidized form GSSG and
a signiﬁcant decrease in the [GSH]/[GSSG] ratio in plasma
[12–16].
The concentrations of plasma ophthalmate increased
∼10-fold (P<. 05) over the concentrations assayed in
the same animals before tumor implantation and over the
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Figure 7: Labeling of ophthalmate (OA) in plasma from the VX2
rabbit model. The turnover of OA was measured in plasma from
rabbits 2 weeks before tumor implantation and 2 weeks after tumor
implantation. OA was found to be similar in rabbits from the
experimental group before and after tumor implantation and to
sham animals (P>. 05, paired t-test and one-sided independent
t-test).
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Figure 8: Cysteine concentration in liver tissue from the VX2 rabbit
model. The concentration of cysteine was measured in liver tissue
samplesfromexperimentalgroup(livertissueadjacenttothetumor
and liver tissue from the lobe without tumor) and liver tissue from
sham animals. Levels of cysteine were found to be signiﬁcantly
lower in liver tissue adjacent to the tumor when compared to liver
tissue from the lobe not containing tumor (P<. 05 paired t-
test). Relative concentrations of cysteine in liver tissue were similar
between the experimental group (both liver adjacent to the tumor
and liver away from tumor) when compared to the sham group
(P>. 05, independent t-test).HPB Surgery 7
concentrations assayed in the control group before and
after the sham operation. However, there was no diﬀerence
in the proﬁle of 2H-labeling of plasma ophthalmate. The
ﬁrst study to recognize ophthalmate as a biomarker for
oxidative stress and hepatic GSH depletion [17]u s e da
metabolomic approach to detect the changes that occur
following acetaminophen-induced hepatotoxicity in mice;
they found an ∼5-fold increase in plasma and liver ophthal-
mate 1 hour after the administration of the drug, and this
ﬁndingwasassociatedwithadepletionofGSHinlivertissue.
No previous study to our knowledge has assessed oxidative
stress metabolites as a possible diagnostic biomarker for liver
cancer. Our results suggest that during early liver tumor
growth there is a signiﬁcant amount of oxidative stress
resulting in increased intracellular glutathione oxidation,
producing GSSG and depleting GSH in the aﬀected part of
the liver, suggested by the elevation of ophthalmate levels in
plasma. Furthermore, analysis of liver tissue samples showed
a decrease in the levels of cysteine, a precursor of GSH, in
the immediate surroundings of the tumor when compared
to the healthy side of the liver. Thus, we hypothesize that the
GSHdepletionassociatedtocysteineconsumptiondescribed
by Soga et al. in 2006 [17] is indeed a local phenomenon, in
thiscase,associatedwiththeearlygrowthofasecondaryliver
tumorwhichmaybecausingoxidativestressinitsimmediate
surroundings.WhilemostofplasmaGSH/GSSGcomesfrom
the liver, their total plasma concentrations and labeling were
not aﬀected in the experimental group. It may suggest the
mass of liver tissue under stress was smaller in proportion to
the mass of liver with a more normal metabolism. This ratio
may change as the tumor grows.
Ophthalmate does not contain a thiol group, thus it
does not participate in the many thiol-dependent reactions
of glutathione. Since the proportion of ophthalmate to glu-
tathione is small, the concentration of ophthalmate should
be reﬂected more rapidly than that of plasma GSH:GSSG
even though the turnover of ophthalmate remained con-
stant. This makes ophthalmate a good model to study
the disturbances of the glutathione buﬀer system during
oxidative stress. The body redox systems, which include
antioxidant enzymes and low molecular weight antioxidants,
may be deregulated in cancer cells along with TNF-α and IL-
6. Moreover, excessive concentrations of free radicals may
overcome normal defense mechanisms and leave DNA at
risk from oxidative modiﬁcations [5, 25]. This imbalance
may enhance tumor growth and disease progression [26].
Higher rates of the oxidative stress metabolites appear to
deﬁne the hallmark of early liver tumor growth which lends
to the potential application for ophthalmate to be used as
a surrogate for early liver growth. The role of ophthalmate
in a cirrhotic liver or in primary liver tumors remains to be
determined in further studies.
The ﬁndings of our study must be interpreted in light of
some limitations. Increment of ophthalmate concentration
was observed in a very early stage of secondary tumor
growth.Duetothenatureoftheanimalmodelchosen,wedo
notknowiftheseﬁndingswillbesimilarinsubsequentstages
of tumor growth, that is, tumor invasion, spread or in cases
of primary liver tumors. Concomitant conditions such as
hepatitis virus infection or portal hypertension may con-
found these ﬁndings. We made an attempt to correlate
the levels of glutathione species, and ophthalmate with the
tumor mass; however, due to the design of the study there
were no signiﬁcant diﬀerences in tumor size/volume in ani-
mals from the experimental group. In addition, the oxidative
stressstatusofananimalwithatumorgrowthmaybeafunc-
tion not only of the tumor nature and its mass, but among
other factors, their cytokine milieu, and nutritional status.
In spite of these boundaries, the present studies showed that
metabolic disturbances in animals with early liver tumor
growth can be detected and, perhaps metabolic signatures of
liver tumor growth, may overcome the limitations of current
biomarkers used in the clinical setting. Currently, there are
many liver biomarkers under investigation. A few of them
recently reported include des-gamma carboxyprothrombin,
lens culinaris agglutinin-reactive α-fetoprotein, human hep-
atocyte growth factor, and insulin-like growth factor-1 [27].
Their clinical relevance is still under study.
In conclusion, the plasma concentration of ophthalmate
signiﬁcantly increased in rabbits after early liver tumor
implantation and growth. This ﬁnding reﬂects an increase
in the oxidative stress placed on the local liver tissue
during early tumor growth. Ophthalmate may prove to be
a surrogate of tumor subsistence and early tumor growth.
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